| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
disease | 0.100 | None | 0.990 | 97 | 8 | 1998 | 2020 | ||||||||
|
interleukin 17A | 0.324 | 0.923 | 4.3E-02 |
|
disease | 0.100 | None | 1.000 | 38 | 8 | 2009 | 2020 | ||||||||
|
cadherin 1 | 0.401 | 0.808 | 0.15 |
|
disease | 0.700 | None | 0.937 | 142 | 7 | 1996 | 2020 | ||||||||
|
toll like receptor 4 | 0.321 | 0.962 | 4.6E-09 |
|
disease | 0.100 | None | 1.000 | 29 | 7 | 2007 | 2020 | ||||||||
|
phospholipase C epsilon 1 | 0.572 | 0.654 | 5.7E-11 |
|
disease | 0.200 | None | 1.000 | 15 | 7 | 2010 | 2020 | ||||||||
|
ERCC excision repair 5, endonuclease | 0.499 | 0.731 | 2.7E-13 |
|
disease | 0.100 | None | 1.000 | 14 | 7 | 2009 | 2018 | ||||||||
|
ERCC excision repair 4, endonuclease catalytic subunit | 0.468 | 0.846 | 1.4E-12 |
|
disease | 0.090 | None | 1.000 | 9 | 7 | 2012 | 2019 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
disease | 0.100 | None | 0.989 | 91 | 6 | 1986 | 2019 | ||||||||
|
X-ray repair cross complementing 1 | 0.421 | 0.923 | 6.3E-09 |
|
disease | 0.100 | None | 0.903 | 31 | 6 | 2000 | 2018 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
disease | 0.400 | None | 0.967 | 30 | 6 | 1987 | 2019 | ||||||||
|
protein kinase AMP-activated catalytic subunit alpha 1 | 0.453 | 0.846 | 0.14 |
|
disease | 0.200 | None | 0.952 | 21 | 6 | 2011 | 2019 | ||||||||
|
ERCC excision repair 2, TFIIH core complex helicase subunit | 0.420 | 0.846 | 7.1E-20 |
|
disease | 0.100 | None | 0.875 | 16 | 6 | 2008 | 2018 | ||||||||
|
DNA methyltransferase 3 alpha | 0.445 | 0.846 | 7.4E-39 |
|
disease | 0.100 | None | 0.929 | 14 | 6 | 2001 | 2019 | ||||||||
|
prostate cancer associated transcript 1 | 0.575 | 0.615 |
|
disease | 0.050 | None | 0.800 | 5 | 6 | 2015 | 2020 | |||||||||
|
erb-b2 receptor tyrosine kinase 2 | 0.328 | 0.923 | 6.0E-03 |
|
disease | 0.600 | None | 0.960 | 374 | 5 | 1988 | 2020 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
disease | 0.100 | None | 0.919 | 62 | 5 | 1994 | 2019 | ||||||||
|
telomerase reverse transcriptase | 0.374 | 0.846 | 0.99 |
|
disease | 0.100 | None | 1.000 | 19 | 5 | 2000 | 2019 | ||||||||
|
transducer of ERBB2, 1 | 0.674 | 0.462 | 0.95 |
|
disease | 0.070 | None | 1.000 | 7 | 5 | 2012 | 2019 | ||||||||
|
XPC complex subunit, DNA damage recognition and repair factor | 0.504 | 0.808 | 3.7E-11 |
|
disease | 0.030 | None | 1.000 | 3 | 5 | 2010 | 2016 | ||||||||
|
interleukin 36 receptor antagonist | 0.638 | 0.538 | 3.4E-08 |
|
disease | 0.010 | None | 1.000 | 1 | 5 | 2015 | 2015 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.100 | None | 0.972 | 218 | 4 | 1991 | 2020 | ||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
disease | 0.100 | None | 0.982 | 109 | 4 | 1999 | 2020 | ||||||||
|
interleukin 1 beta | 0.276 | 0.962 | 0.13 |
|
disease | 0.100 | None | 0.889 | 63 | 4 | 2000 | 2018 | ||||||||
|
mutL homolog 1 | 0.399 | 0.808 | 3.4E-05 |
|
disease | 0.100 | None | 0.962 | 52 | 4 | 1999 | 2020 | ||||||||
|
prostate stem cell antigen | 0.555 | 0.615 | 0.17 |
|
disease | 0.200 | None | 1.000 | 44 | 4 | 2008 | 2019 |